Citation Indexes Can Help Halt The Spread Of Fraudulent Research

Last May at the American Medical Association's International Congress on Peer Review in Biomedical Publication, I presented a report on the impact of fraud on scientific literature. Much of the current debate on this issue has focused on the small, but growing, number of papers reporting falsified research that escape the traditional quality control filter of peer review. But little attention has been paid to the question of whether and how these papers impact on research. This question is relev

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Drummond Rennie, West Coast editor of the Journal of the American Medical Association and director of the AMA Congress, suggested that I examine the work of Stephen E. Breuning, the first researcher to have been convicted of scientific fraud in federal court. While at the Coldwater Regional Center for Developmental Disabilities, Michigan, and the University of Pittsburgh, Breuning published a number of studies from 1980 to 1984 on the use of drugs to control hyperactive retarded children, claiming that stimulant drugs were more effective and had fewer side effects than tranquilizers, the traditional drug therapy for retarded children. Experts in the field claim that Breuning's work was influential and led some states to change their policies on treating retarded children. But an investigation by the National Institute of Mental Health, initiated after a colleague challenged Breuning's work, concluded that he had not conducted the studies and had "knowingly, willfully, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies